Data-Driven Analysis of Psychiatric Disorders in Type 2 Diabetic Patients and Associations with Demographic Factors

Abstract

This study investigates the prevalence of anxiety, depression, and stress in patients with type 2 diabetes and explores their association with demographic factors. 364 patients were selected using a convenience sampling method from the diabetes clinic at Taleghani Hospital in Tehran, Iran. Psychological assessments were conducted using the Depression, Anxiety, and Stress Scale (DASS-21), and data analysis was performed using SPSS at a significance level of 0.05. The study population consisted of 40% males and 60% females, with a mean age of 51 years. The prevalence of anxiety, depression, and stress was notably high, at 92.2%, 79.8%, and 83.7%, respectively. A significant correlation was found between educational level and all three psychological disorders, while no association was observed between stress and age. Additionally, no significant relationships were identified between stress, anxiety, or depression with the duration of diabetes, marital status, or age. However, a clear association was noted between diabetes-related complications and anxiety. The findings underscore the importance of screening for mental health conditions in patients with type 2 diabetes to ensure timely intervention and management of these psychosocial issues.

References

[1] Sun, N., Lou, P., Shang, Y., Zhang, P., Wang, J., Chang, G., & Shi, C. (2016). Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ Open, 6(8), e012540. doi:10.1136/bmjopen-2016-012540
[2] Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137–49. doi:10.1016/j.diabres.2013.11.002 CrossRefPubMedGoogle Scholar
[3] Grigsby, A.B., Anderson, R.J., Freedland, K.E., Clouse, R.E., Lustman, P.J. (2002). Prevalence of anxiety in adults with diabetes: a systematic review, J. Psychosom. Res. 53 (December (6)) 1053–1060. PubMed PMID: 12479986. Epub 2002/12/14.
[4] Mirzaei, M., Daryafti, H., Fallahzadeh, H., Azizi, B. (2016). Evaluation of Depression, Anxiety and Stress in Diabetic and Non-Diabetic Patients. JSSU, 24(5), 387-397.
[5] Egede, L.E., & Dismuke, C.E. (2012). Serious Psychological Distress and Diabetes: A Review of the Literature. Curr Psychiatry Rep 14, 15–22. https://doi.org/10.1007/s11920-011-0240-0
[6] Robinson, N., Fuller, J.H., Edmeades, S.P. (1988). Depression and diabetes. Diabetic medicine, 5(3), 268-74.
[7] Brown, T.A., Chorpita, B.F., Korotitsch, W., Barlow, D.H. (1997). Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther 35, 79-89.
[8] Clara, I.P., Cox, B.J., Enns, M.W. (2001). Confirmatory factor analysis of the Depression-Anxiety-Stress Scales in depressed and anxious patients. J Psychopathol Behav Assess 23, 61-7.
[9] Henry, J.D., & Crawford, J.R. (2005). The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 44, 227-39.
[10] Taheri, N., Hojjati, H., Mousavi, M., Afra, A., Dehghan, B. (2011). The Survey of Anxiety and Depression Prevalence in Diabetic Patient Referred to Abadan Taleghani and Khorramshahr Valiasr Hospitals. JDN, 1(2), 21-31. [In Persian]
[11] Asad Abadi, A., Aziz Zadeh Foroozi, M., Fuladvandi, G.R., Fuladvandi, M., Lashkari, T., Malekian, L. (2014). Effectiveness of stress management training on improved quality of life in patients with type 2 diabetes. JHPM, 2(3), 16-24. [In Persian]
[12] Esmaili, A., Asadnia, S., Easazadeh, A., Amirsardari, L., Issazadeghan, A., Ansari, B. (2013). Evaluation of the effectiveness of cognitive behavioral therapy on decreasing depression levels and improving the lifestyle of patients with type 2 diabetes. Urmia Med J, 24(10), 822.
[13] Ranjbar, K.H., Sharif, F., Dzhbkhsh, T. (2006). Frequency and severity of depression in diabetic adults using tablet and insulin. HMJ, 10(4), 363-9. [In Persian]
[14] Moayedi, F., Zare, S., Nikbakht, A. (2012). Anxiety and depression in diabetic patients referred to Bandar Abbas diabetes clinic. HMJ, 18(1), 65-71. [In Persian]
[15] Mirzaei, M., Daryafti, H., Fallahzadeh, H., Azizi, B. (2016). Evaluation of Depression, Anxiety and Stress in Diabetic and Non-Diabetic Patients. JSSU, 24(5), 387-97. [In Persian]
[16] Attari, A., Mehrabi, A., Davazdah Emamy, M.H., Roshan, R. (2009). The Effectiveness of Cognitive-Behavioral Stress Management Training on Glycemic Control and Depression in Patients with Type 2 Diabetes. IJEM, 11(4), 385-92. [In Persian]

[17] Ansari, M., Shams Sfandabad, H., Hakami, M. (2011). The effect of training anger control and stress management on blood glucose levels in people with diabetes. HPJ, 1(3), 47-60. [In Persian]
[18] Zahrakar, K. (2012). A Study of Effectiveness of Group-based Rational, Emotive, Behavior Therapy (REBT) on Decrease of Stress among Diabetic Patients. JKH, 7(4), 160-4. [In Persian]
[19] Amiri, M., Aghaei, A., Abedi, A., Safari, Y. (2014). Effectiveness of stress inoculation training (SIT) on depression in diabetics. HPJ, 3(1), 16-28. [In Persian]
[20] Mahmoodi, G.H., Abolghasemi, S.H., Darvishi, H. (2012). The effect of stress inoculation training on reducing psychological pressure in patients with type 2 diabetes. JHB, 2(2), 41-4.
[21] Alhani, F., Mohajeri Tehrani, M.R., Sharifirad, G., Shojaeezadeh, D., Tol, A. (2012). Effect of empowerment model on distress and diabetes control in patients with type 2 diabetes. JNE, 1(1), 38-47. [In Persian]
[22] Zare, S., Nikbakht, A., Moayedi, F. (2014). Anxiety and depression in diabetic patients referred to Bandar Abbas diabetes clinic. HMJ, 18(1), 65-71. [In Persian]
[23] Mehrabi, A., Fata, L., Davazdah Emami, M.H., Rajab, A. (2008). Effect of stress management training based on Cognitive-behavioral theory on glycemic control and reduces the emotional problems of patients with type 1 diabetes. IJEM, 8(2), 103-14.
[24] Khosravi, A., Aghayan, S., Mousavi, S.A., Razavian–zade, N., Norouzi, N. (2008). Depression and General Health Status in Type II Diabetic Patients. JKH, 3(1), 44-8. [In Persian]
[25] Sayehmiri, K., Sheykhi, A., Rabiei Fakhr, F., Yadegarazadi, A., Azami, M. (2016). The prevalence of depression in patients with type 2 diabetes in Iran- systematic review and meta-analysis study. IJEM, 15(4), 217-24. [In Persian]
[26] Park, C.Y., Kim, S.Y., Gil, J.W., Park, M.H., Park, J.H., Kim, Y. (2015). Depression among Korean adults with type 2 diabetes mellitus: Ansan-community-based epidemiological study. PHRP, 6(4), 224-32.
[27] Kruse, J., Schmitz, N., Thefeld, W. (2003). On the association between diabetes and mental disorders in a community sample. Results from the German National Health Interview and Examination Survey. JDC, 26(6), 1841-6.
[28] Ferreira, M.C., Piaia, C., Cadore, A.C., Antoniolli, M.A., Gamborgi, G.P., Oliveira, P.P. (2015). Clinical variables associated with depression in patients with type 2 diabetes. Revista da Assoc Med Brasileira, 61(4), 336-40.
[29] Taherian, M., Tajabadi, Z., Azhideh, A., Taherian, R. (2021). Methotrexate-induced neurocognitive late effects in treatment of pediatric acute lymphoblastic leukemia: a review. Human, Health and Halal Metrics, 2(1), 63-74.
[30] Ashrafi, F., Rezaei, A., Azhideh, A., Tabeie, F., Gachkar, L., Ahmadi, M.A., Yousefi-Asl, M., Zali, A., Khoshnoud, R.J. (2020). Effectiveness of Extremely Low Frequency Electromagnetic Field and Pulsed Low Level Laser Therapy in Acute Stroke Treatment. International Clinical Neuroscience Journal, 7(3), 127.
[31] Mikaliukstiene, A., Zagminas, K., Juozulynas, A., Narkauskaite, L., Salyga, J., Jankauskiene, K., et al. (2014). Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania. Med Sci Monitor: Inter Med J Experiment Clinic Res, 20, 182-90.
[32] Taherian, M., Tajabadi, Z., Azhideh, A., Taherian, R. (2021). Methotrexate-induced neurocognitive late effects in treatment of pediatric acute lymphoblastic leukemia: a review. Human, Health and Halal Metrics, 2(1), 63-74.
[33] Mirzaei, A., Mohammadi, S., Mazloomy, S.S. (2008). Study of Depression Prevalence in the Patients with Type II Diabetes Referring to Yazd Diabetes Research Centers in 2008. TBJ, 7(1-2), 30-5. [In Persian]
[34] Radpour, A., Bahrami-Motlagh, H., Taaghi, M.T., Sedaghat, A., Karimi, M.A., Hekmatnia, A., Haghighatkhah, H.R., Sanei-Taheri, M., Arab-Ahmadi, M., Azhideh, A. (2020). COVID-19 evaluation by low-dose high resolution CT scans protocol. Academic Radiology, 27(6), 901.
[35] Arefi Shirvan, R., Setaredan, S.K., Motie Nasrabadi, A. (2018). Classification of Mental Stress Levels by Analyzing fNIRS Signal Using Linear and Non-linear Features. 5(2), 55-61. ISSN 2383-2096.
[36] Kasiri Dolat Abadi, N., Mortezapour, S., Hosseini, M. (2010). Depression in diabetes patients with type 2, Isfahan, Iran. J Health System Res, 6(2), 308-14.